(Q40280020)

19 September 2017

Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I. (English)

1 reference

19 September 2017

mucopolysaccharidosis I

1 reference

based on heuristic

inferred from title

obstructive sleep apnea

1 reference

based on heuristic

inferred from title

author

Vassili Valayannopoulos

9

object named as

Vassili Valayannopoulos

1 reference

19 September 2017

Johan Moreau

1

1 reference

19 September 2017

Anais Brassier

2

1 reference

19 September 2017

Alessandro Amaddeo

3

1 reference

19 September 2017

Benedicte Neven

4

1 reference

19 September 2017

Catherine Caillaud

5

1 reference

19 September 2017

Allel Chabli

6

1 reference

19 September 2017

Marta Fernandez-Bolanos

7

1 reference

19 September 2017

Jorge Olmo

8

1 reference

19 September 2017

Brigitte Fauroux

10

1 reference

19 September 2017

22 October 2015

1 reference

Molecular Genetics and Metabolism

19 September 2017

1 reference

19 September 2017

116

1 reference

19 September 2017

4

1 reference

19 September 2017

275-280

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

19 September 2017

1 reference

Respiratory and sleep disorders in mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Home sleep study characteristics in patients with mucopolysaccharidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Polysomnographic characteristics in patients with mucopolysaccharidoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Fluorimetric assay for prenatal detection of Hurler and Scheie homozygotes or heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.10.004

10.1016/J.YMGME.2015.10.004

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference